搜索
Vaxart Inc
VXRT添加自选
0.320USD
0.0000.00%
交易中 （美东）报价延迟15分钟
73.03M总市值
亏损市盈率 TTM
关于 Vaxart Inc 公司
Vaxart, Inc. 是一家临床阶段的生物技术公司，主要专注于基于其载体佐剂抗原标准化技术 (VAAST) 专有口服疫苗平台开发口服重组疫苗。其疫苗设计为使用药丸给药，可在无需冷藏的情况下储存和运输，并消除针刺伤的风险。其开发计划包括旨在预防诺如病毒（急性胃肠炎的病因）、冠状病毒（包括 SARS-CoV-2 (COVID-19)）和流感的药丸疫苗。此外，该公司还为其针对宫颈癌和人乳头瘤病毒引起的发育不良的治疗性疫苗候选物生成了临床前数据。该公司的平台技术采用基于载体的方法，由各种组件组成，例如载体（腺病毒 5 型 (Ad5)；抗原 (Ad5 DNA)；佐剂（Toll 样受体 3 (TLR3)）和其专有的肠溶片。
Vaxart Inc简介
公司代码VXRT
公司名称Vaxart Inc
上市日期Mar 17, 1980
CEOMr. Steven (Steve) Lo
员工数量105
证券类型Ordinary Share
年结日Mar 17
公司地址170 Harbor Way, Suite 300
城市SOUTH SAN FRANCISCO
上市交易所US 'Other OTC' and Grey Market
国家United States of America
邮编94080
电话16505503500
网址https://vaxart.com/
公司代码VXRT
上市日期Mar 17, 1980
CEOMr. Steven (Steve) Lo
Vaxart Inc公司高管
名称
名称/职务
职务
持股
持股变动
Mr. Edward B. Berg
Mr. Edward B. Berg
Senior Vice President, General Counsel
Senior Vice President, General Counsel
435.74K
+0.24%
Mr. Jeroen Grasman
Mr. Jeroen Grasman
Chief Financial Officer, Principal Accounting Officer and Principal Financial Officer
Chief Financial Officer, Principal Accounting Officer and Principal Financial Officer
350.00K
--
Mr. Steven (Steve) Lo
Mr. Steven (Steve) Lo
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
237.34K
+0.03%
Dr. Elaine J. Heron, Ph.D.
Dr. Elaine J. Heron, Ph.D.
Independent Director
Independent Director
80.57K
+0.12%
Dr. Sean N. Tucker, Ph.D.
Dr. Sean N. Tucker, Ph.D.
Senior Vice President, Chief Scientific Officer
Senior Vice President, Chief Scientific Officer
--
--
Mr. W. Mark Watson
Mr. W. Mark Watson
Lead Independent Director
Lead Independent Director
--
--
Dr. James F. Cummings, M.D.
Dr. James F. Cummings, M.D.
Chief Medical Officer
Chief Medical Officer
--
--
Mr. Kevin P. Finney
Mr. Kevin P. Finney
Independent Director
Independent Director
--
--
Mr. Matt Stein
Mr. Matt Stein
IR Contact Officer
IR Contact Officer
--
--
Ms. Laurie Hastings
Ms. Laurie Hastings
Senior Vice President of Human Resources
Senior Vice President of Human Resources
--
--
查看更多
名称
名称/职务
职务
持股
持股变动
Mr. Edward B. Berg
Mr. Edward B. Berg
Senior Vice President, General Counsel
Senior Vice President, General Counsel
435.74K
+0.24%
Mr. Jeroen Grasman
Mr. Jeroen Grasman
Chief Financial Officer, Principal Accounting Officer and Principal Financial Officer
Chief Financial Officer, Principal Accounting Officer and Principal Financial Officer
350.00K
--
Mr. Steven (Steve) Lo
Mr. Steven (Steve) Lo
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
237.34K
+0.03%
Dr. Elaine J. Heron, Ph.D.
Dr. Elaine J. Heron, Ph.D.
Independent Director
Independent Director
80.57K
+0.12%
Dr. Sean N. Tucker, Ph.D.
Dr. Sean N. Tucker, Ph.D.
Senior Vice President, Chief Scientific Officer
Senior Vice President, Chief Scientific Officer
--
--
Mr. W. Mark Watson
Mr. W. Mark Watson
Lead Independent Director
Lead Independent Director
--
--
常见问题
Vaxart Inc的前五大股东是谁？
Vaxart Inc 的前五大股东如下：Mr. Edward B. Berg
有多少机构持有Vaxart Inc(VXRT)的股份？
截至2026Q1，共有188家机构持有Vaxart Inc的股份，合计持有的股份价值约为120.77K，占公司总股份的0.05%。与2025Q4相比，机构持股有所增加，增幅为-50563267.00。
